Independent Bank (NASDAQ:INDB) reported quarterly earnings of $1.69 per share which beat the analyst consensus estimate of $1.65 by 2.42 percent. This is a 3.68 percent increase over earnings of $1.63 per share from the same period last year.
BetterLife’s Non-Hallucinogenic LSD’s Clinical Studies, Braxia’s Psychedelic Treatments Continue
Psychedelics biotech BetterLife Pharma (OTCQB: BETRF) announced its non-hallucinogenic LSD derivative, BETR-001, is progressing through IND-enabling studies toward expected clinical studies targeting Major Depressive Disorder (MDD.)
